GSK3 controls Treg development and immune homeostasis, suggesting critical pathways in autoimmunity and tumor immunity.
Tregs are critical regulators of the immune response, but the cellular and metabolic signaling pathways that control their development and homeostasis remain to be determined. We found that glycogen synthase kinase-3 (GSK3), a kinase that integrates signals from Akt and mTOR, was essential for Treg development, restraining fatal autoimmunity. Loss of Gsk3 led to metabolic rewiring in Tregs, with disordered nucleotide metabolism and activation of OxPhos. Acute deletion of Gsk3 did not affect Treg frequency or numbers but induced an effector gene expression program and led to the formation of populations with pro-inflammatory signatures. The acute loss of Gsk3 in Tregs profoundly enhanced anti-tumoral immune responses and suppressed tumor growth. Overall, we demonstrate that GSK3 critically regulates Treg homeostasis and anti-tumor immune responses.
No takes yet. Share an insight, caveat, or question.
Kandasamy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: